Elephas Biosciences Secures $40 Million Funding for Innovative Tumor Profiling Technology Elephas Biosciences Corporation has raised $40 million to advance its live tumor profiling platform, enhancing immunotherapy predictions for better patient outcomes.

Elephas Biosciences Secures $40 Million Funding for Innovative Tumor Profiling Technology #USA #Immunotherapy #Madison,_Wisconsin #tumor_profiling #Elephas

Aignostics Unveils AI-Powered Application for Tumor Microenvironment Profiling Aignostics has launched Atlas HE-TME, an AI application that enhances tumor microenvironment analysis, promising faster and high-quality results for cancer research.

Aignostics Unveils AI-Powered Application for Tumor Microenvironment Profiling #USA #Berlin #Aignostics #tumor_profiling #Atlas_HE-TME

Illumina's Expanded Oncology Portfolio Sets New Standards in Precision Medicine Illumina enhances its clinical oncology offerings, facilitating greater access to precision therapies, ultimately transforming cancer treatment standards.

Illumina's Expanded Oncology Portfolio Sets New Standards in Precision Medicine #San_Diego #US #Illumina #Precision_Oncology #tumor_profiling